LVW Advisors LLC Sells 4,160 Shares of Oscar Health, Inc. (NYSE:OSCR)

LVW Advisors LLC reduced its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 19.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 16,849 shares of the company’s stock after selling 4,160 shares during the period. LVW Advisors LLC’s holdings in Oscar Health were worth $251,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Prevail Innovative Wealth Advisors LLC purchased a new position in shares of Oscar Health in the 4th quarter valued at $92,000. Handelsbanken Fonder AB purchased a new position in Oscar Health during the 4th quarter worth $110,000. Focus Financial Network Inc. ADV purchased a new position in Oscar Health during the 4th quarter worth $152,000. Public Employees Retirement System of Ohio purchased a new position in Oscar Health during the 3rd quarter worth $168,000. Finally, Victory Capital Management Inc. grew its stake in Oscar Health by 37.7% during the 4th quarter. Victory Capital Management Inc. now owns 18,852 shares of the company’s stock worth $172,000 after buying an additional 5,159 shares during the last quarter. 75.70% of the stock is owned by institutional investors.

Oscar Health Trading Down 10.4 %

Shares of OSCR stock opened at $15.82 on Monday. The business has a 50-day simple moving average of $19.49 and a 200-day simple moving average of $15.42. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.10 and a quick ratio of 1.10. Oscar Health, Inc. has a 52-week low of $4.72 and a 52-week high of $23.44.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.34. The business had revenue of $2.14 billion during the quarter, compared to analysts’ expectations of $1.99 billion. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The company’s revenue for the quarter was up 45.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.18) EPS. Research analysts predict that Oscar Health, Inc. will post -0.05 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on OSCR shares. Baird R W upgraded Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. The Goldman Sachs Group boosted their target price on Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a research note on Thursday, May 9th. Robert W. Baird started coverage on Oscar Health in a research report on Thursday, May 30th. They set an “outperform” rating and a $28.00 price target for the company. Bank of America reaffirmed a “neutral” rating and set a $21.00 price target (down previously from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Finally, Piper Sandler started coverage on Oscar Health in a research report on Wednesday, June 26th. They set an “overweight” rating and a $25.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $19.75.

Insider Buying and Selling

In related news, COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $362,092.22. Following the completion of the transaction, the chief operating officer now owns 65,316 shares of the company’s stock, valued at approximately $1,271,049.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Mario Schlosser sold 5,808 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $113,023.68. Following the completion of the sale, the insider now directly owns 65,920 shares in the company, valued at $1,282,803.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $362,092.22. Following the completion of the sale, the chief operating officer now owns 65,316 shares of the company’s stock, valued at $1,271,049.36. The disclosure for this sale can be found here. In the last 90 days, insiders sold 81,655 shares of company stock valued at $1,589,006. 25.11% of the stock is owned by company insiders.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.